Impact of a Screening Program in the Diagnosis, Surgical Treatm ent and Management of Breast Cancer

I. Lete, M. Aguiar, Arguine Andonegui, Nagore Zeberio, M. Cuadra, J. Mendizabal, J. Gorostiaga
{"title":"Impact of a Screening Program in the Diagnosis, Surgical Treatm ent and Management of Breast Cancer","authors":"I. Lete, M. Aguiar, Arguine Andonegui, Nagore Zeberio, M. Cuadra, J. Mendizabal, J. Gorostiaga","doi":"10.4172/1948-5956.1000537","DOIUrl":null,"url":null,"abstract":"Introduction: The effects of early detection on treatment need to be evaluated. The objective of this study was to assess the impact of the Basque breast cancer early detection program (BCEDP) on breast cancer surgery in our hospital. Materials and Methods: A retrospective study was conducted of women who underwent surgery for breast cancer between 1 January 2015 and 31 December 2016. Participants were classified into: Group A, those referred from the screening program after routine mammography; or group B, those referred from primary care or other gynecological clinics within our health region. Results: In the study period, 630 women were diagnosed with and treated for breast cancer. Their mean age was 60.2 years (standard deviation 5.4). Out of these, 220 (35%) referred from the BCEDP formed group A, the other 410 women (65%) forming group B. Invasive cancer was diagnosed in 185 women in group A (84%) and in 370 (90.2%) in group B (p=0.02). Regarding treatment, mastectomies were carried out in 47 women (21.4%) in Group A and 225 (54.9%) in group B (p<0.001); axillary lymphadenectomies were performed in 31 women (14.1%) in Group A and 83 (20.2%) in Group B, (p=0.02); and adjuvant chemotherapy was given in 66 women (30%) in Group A and 148 (36.1%) in Group B (p<0.001). Conclusion: In our setting, breast cancer patients referred through the BCEDP have earlier stage cancer, can be expected to benefit from less radical surgery, have lower proportion of axillary lymph node involvement and require less adjuvant chemotherapy.","PeriodicalId":15170,"journal":{"name":"Journal of Cancer Science & Therapy","volume":"23 1","pages":"152-155"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Science & Therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/1948-5956.1000537","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: The effects of early detection on treatment need to be evaluated. The objective of this study was to assess the impact of the Basque breast cancer early detection program (BCEDP) on breast cancer surgery in our hospital. Materials and Methods: A retrospective study was conducted of women who underwent surgery for breast cancer between 1 January 2015 and 31 December 2016. Participants were classified into: Group A, those referred from the screening program after routine mammography; or group B, those referred from primary care or other gynecological clinics within our health region. Results: In the study period, 630 women were diagnosed with and treated for breast cancer. Their mean age was 60.2 years (standard deviation 5.4). Out of these, 220 (35%) referred from the BCEDP formed group A, the other 410 women (65%) forming group B. Invasive cancer was diagnosed in 185 women in group A (84%) and in 370 (90.2%) in group B (p=0.02). Regarding treatment, mastectomies were carried out in 47 women (21.4%) in Group A and 225 (54.9%) in group B (p<0.001); axillary lymphadenectomies were performed in 31 women (14.1%) in Group A and 83 (20.2%) in Group B, (p=0.02); and adjuvant chemotherapy was given in 66 women (30%) in Group A and 148 (36.1%) in Group B (p<0.001). Conclusion: In our setting, breast cancer patients referred through the BCEDP have earlier stage cancer, can be expected to benefit from less radical surgery, have lower proportion of axillary lymph node involvement and require less adjuvant chemotherapy.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
筛查项目对乳腺癌诊断、手术治疗和管理的影响
引言:早期发现对治疗的影响有待评估。本研究的目的是评估巴斯克乳腺癌早期检测项目(BCEDP)对我院乳腺癌手术的影响。材料和方法:对2015年1月1日至2016年12月31日期间接受乳腺癌手术的女性进行回顾性研究。参与者分为:A组,在常规乳房x光检查后从筛查项目转介的患者;或B组,从我们卫生区域内的初级保健或其他妇科诊所转诊的患者。结果:在研究期间,有630名女性被诊断患有乳腺癌并接受了治疗。平均年龄60.2岁(标准差5.4)。其中,来自BCEDP的220人(35%)组成了A组,其他410名女性(65%)组成了B组。A组中有185名女性(84%)被诊断为浸润性癌症,B组中有370名(90.2%)被诊断为浸润性癌症(p=0.02)。治疗方面,A组47例(21.4%)行乳房切除术,B组225例(54.9%)行乳房切除术(p<0.001);A组行腋窝淋巴结切除术31例(14.1%),B组行腋窝淋巴结切除术83例(20.2%),差异有统计学意义(p=0.02);A组66例(30%),B组148例(36.1%)接受辅助化疗(p<0.001)。结论:在我们的情况下,通过BCEDP转诊的乳腺癌患者是早期癌症,可以预期从较少的根治性手术中获益,腋窝淋巴结受累率较低,需要较少的辅助化疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Role of Oxygen and Nitrogen Radicals in the Mechanism of Anticancer Drug Cytotoxicity. Durable Response to Immune Checkpoint Blockade Plus Albumin-Bound Paclitaxel in Two Osimertinib-Refractory Patients with EGFR-mutated Lung Adenocarcinoma Significant Role of MCM10 in Lung Adenocarcinoma: Promote Viability and Migration Cisplatin-Based Chemotherapy of Human Cancers FLOT1 is a novel target of ovarian cancer for diagnosis and treatment
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1